Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma

by John Apostolidis, Ayman Sayyed, Mohammed Darweesh, Panayotis Kaloyannidis, Hani Al Hashmi
Published 2020-01-01

Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

by Panayotis Kaloyannidis, Eshrak Al Shaibani, Asif Moinnudin, Khalid Al Anezi, Hani Al Hashmi
Published 2021-03-01

De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin’s Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation

by Panayotis Kaloyannidis, Eshrak Al Shaibani, Miral Mashhour, Mohammed Gamil, Ioannis Apostolidis, Hani Al Hashmi, Khalid Ahmed Al Anazi
Published 2018-01-01

Management of adult immune thrombocytopenia: Recommendations by an expert Saudi panel

by Hazzaa Al-Zahrani, Aamer Aleem, Fahad Al Mohareb, Said Yousuf Ahmed, Ahmed M Al-Suliman, Hussain H Al Saeed, Mubarak S Al-Ghamdi, Hani Al-Hashmi
Published 2019-01-01

Management of myelodysplastic syndromes: Expert consensus opinion from the Saudi MDS Working Group

by Ahmed Alaskar, Abdul Kareem Al Momen, Ahmad Al-Saeed, Ahmed Al Sagheir, Amr Hanbali, Ayman Al-Hejazi, Hani Al-Hashmi, Khalid Al-Anazi, Mohsen Al Zahrani, Saud Abu Harbesh, Zayed Al-Zahrani
Published 2014-01-01

Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

by Nawal AlShehry, Syed Ziauddin A Zaidi, Ahmed AlAskar, Abdurahman Al Odayani, Jawaher Mubarak Alotaibi, Ahmed AlSagheir, Ayman Al-Eyadhy, Saud Balelah, Abdul Salam, Abdul Rehman Zia Zaidi, Diea Alawami, Mohammed S Alshahrani, Nour AlMozain, Yem M Abulhamayel, Reem Al Qunfoidi, Mona Alfaraj, Nahid Qushmaq, Rehab Alansari, Afra Dayel, Ghada Elgohary, Ahmed Al Bahrani, Arwa A Nabhan Abdelhameed, Hazza Abdullah AlZahrani, Hanan Alturkistani, Nada AlShehry, Mohammed Abdulhameed Albalawi, Ibrahim Elalfy, Hind Alhumaidan, Hani Al-Hashmi
Published 2021-01-01